Delivery Order SPE2DB22D2009-SPE2DB25FM1AY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $6,100.64. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a small-value pharmaceutical procurement executed through the DLA's medical supply chain. The award was made on a competitive basis with no set-aside designation, and the product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections with a ceiling value of $2,178.54. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections valued at $7,625.80 on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections at a ceiling value of $1,525.20. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 6, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency awarded a $13,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. The contract, which is set to be completed by September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded competitively without a set-aside designation, reflecting the contractor's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a ceiling value of $3,157.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a small-value pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $7,625.80. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 5, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections at a firm fixed price ceiling value of $30,324. The order, with an ultimate completion date of September 17, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was awarded without set-aside restrictions on a competitive basis, consistent with the company's standard...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1AYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, with a ceiling value of $7,396.31 under a firm fixed-price contract. This is a non-set-aside competitive award with performance completion scheduled for August 22, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving the Defense Health Agency and military healthcare systems, AmerisourceBergen Drug Corp has demonstrated substantial capability to fulfill federal medical procurement requirements across multiple therapeutic domains. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/21/25 |